Gene fusions and chimeric RNAs, and their implications in cancer

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Gene fusions are recognized as key cancer biomarkers and therapeutic targets.
• Chimeric RNAs were traditionally considered exclusive products of gene fusions and thus cancer-specific.
• Recent studies reveal chimeric RNAs can form via intergenic splicing in normal physiology.

Purpose of the Study:

• To provide an overview of gene fusions and chimeric RNAs, highlighting their distinctions.
• To discuss the implications of non-gene fusion-derived chimeric RNAs in cancer detection.
• To explore the novel "horse before the cart" hypothesis regarding chimeric RNA and gene fusion generation.

Main Methods:

• Literature review and synthesis of current research on gene fusions and chimeric RNAs.
• Comparative analysis of chimeric RNA biogenesis pathways.
• Theoretical exploration of the reciprocal relationship between chimeric RNAs and gene fusions.

Main Results:

• Chimeric RNAs can be generated independently of gene fusions through intergenic splicing.
• The presence of chimeric RNAs in normal tissues complicates their role as exclusive cancer biomarkers.
• Gene fusions can produce chimeric RNAs, but chimeric RNAs may also influence gene fusion formation.

Conclusions:

• The traditional view of chimeric RNAs as solely cancer-specific is challenged.
• The discovery of chimeric RNAs in normal physiology necessitates a re-evaluation of their diagnostic utility.
• The "horse before the cart" hypothesis offers a new perspective on the interplay between chimeric RNAs and gene fusions, potentially impacting cancer research and treatment strategies.